The business of science and the science of business in the quest for an AIDS vaccine
- 5 March 1999
- Vol. 17 (9-10) , 1211-1222
- https://doi.org/10.1016/s0264-410x(98)00345-4
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Euphoria Fades as Threats EmergeScience, 1998
- Counting NIH's Fiscal ChickensScience, 1998
- New Hunt for the Roots of ResistanceScience, 1998
- Senate Panel Backs Large NIH IncreaseScience, 1998
- The Future of U.S. Science PolicyScience, 1998
- Controlling HIV pathogenesis: the role of the noncytotoxic anti-HIV response of CD8+ T cellsImmunology Today, 1996
- US science funding finally hits the frontierNature, 1996
- Press panel recommends a unified budget for scienceNature, 1995
- Overview: practical insights from comparative immunology and pathogenesis of AIDS, hepatitis B, and measles for developing an HIV vaccineVaccine, 1995
- Cultivation of the Lansing Strain of Poliomyelitis Virus in Cultures of Various Human Embryonic TissuesScience, 1949